Since July this year, Ravago Manufacturing's Steinfurt production site has been certified to international medical devices quality management standard DIN EN ISO 13485. This was announced by the company in late November. The Steinfurt site produces compounds based on amorphous and semi-crystalline thermoplastics for applications in medical and pharmaceutical technology and in in vitro diagnostics. This standard focuses on compliance with regulatory requirements and product safety including risk management. Its requirements may also be extended to manufacturers of the raw materials used in medical devices. Ultrapolymers, a member of the Ravago Group as well, distributes these medical compounds throughout Europe. The compounds produced in Steinfurt complement the range of Ultrapolymers' thermoplastics for this sector which also include polyolefins, styrenics, polymethyl methacrylates, polycarbonates and TPS produced by leading polymer manufacturers.